Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent
O. A. El‐Kawy, Gamal Abdelaziz
Topics & Concepts
PirarubicinDoxorubicinChemistryBladder cancerIn vivoAnthracyclineUrinary systemCytotoxicityCancer researchPharmacologyUrologyTopoisomeraseClearanceCancerIn vitroMedicineInternal medicineChemotherapyBiochemistryBreast cancerBiologyBiotechnologyBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrinary Tract Infections Management